Immunotherapy in Head and Neck Cancer-Where Are We Now and Where Are We Headed?

Int J Mol Sci · 2026 · PMC12842567 · PMID 41596632

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

The combination of immunotherapy with chemotherapy only demonstrated a positive trend in survival.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.